Paid Clinical Trials Washington, D.C.

Discover 820 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 820

Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Washington, Baltimore, Frederick, Norfolkshow 42 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)

Recruiting

PHASE3

Sponsor:

AbbVie

Location:

Washington, Philadelphia, Charlotte, Bostonshow 7 more

Code:

NCT04064827

Conditions

Chronic Kidney Disease (CKD)

Secondary Hyperparathyroidism (SHPT)

Eligibility Criteria

Sex: All

Age: 0 - 9

Healthy Volunteers: Not accepted

Interventions

Paricalcitol

A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer

Recruiting

PHASE1

PHASE2

Sponsor:

Takeda

Location:

Washington, New York, New Haven, Indianapolisshow 7 more

Code:

NCT04844073

Conditions

Squamous Cell Cancer of Head and Neck (SCCHN)

Non-small Cell Lung Cancer (NSCLC)

Colorectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TAK-186

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

Recruiting

Sponsor:

American Thrombosis and Hemostasis Network

Location:

Washington, New Hyde Park, Greenville, Clevelandshow 19 more

Code:

NCT04647227

Conditions

Hemophilia A With Inhibitor

Hemophilia B With Inhibitor

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

coagulation factor VIIa [recombinant]-jncw

A Prospective Longitudinal Study in Adults with Multifocal Motor Neuropathy

Recruiting

Sponsor:

argenx

Location:

Washington, Philadelphia, New Brunswick, Pittsburghshow 23 more

Code:

NCT05988073

Conditions

Multifocal Motor Neuropathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Recruiting

PHASE3

Sponsor:

Sanofi

Location:

Washington, Vienna, Fairfax, Luthervilleshow 78 more

Code:

NCT06141473

Conditions

Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Frexalimab

Teriflunomide

Placebo infusion

Placebo tablet

MRI contrast-enhancing agents

A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung Cancer

Recruiting

PHASE2

Sponsor:

Fujifilm Pharmaceuticals U.S.A., Inc.

Location:

Washington, Fairfax, Philadelphia, Morristownshow 16 more

Code:

NCT05318573

Conditions

Advanced Urothelial Carcinoma

Advanced Non Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

FF-10832

Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Recruiting

PHASE1

Sponsor:

Allogene Therapeutics

Location:

Washington, New York, New Haven, Detroitshow 6 more

Code:

NCT04696731

Conditions

Advanced/Metastatic Clear Cell Renal Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

ALLO-316

ALLO-647

Fludarabine

Cyclophosphamide

Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

Recruiting

Sponsor:

Carelon Research

Location:

Washington, Philadelphia, Pittsburgh, New Yorkshow 20 more

Code:

NCT05268094

Conditions

Congenital Heart Disease in Children

Eligibility Criteria

Sex: All

Age: 1 - 30

Healthy Volunteers: Not accepted

Interventions

Ductal Arterial Stent

Systemic-to-Pulmonary Artery Shunt

PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis

Recruiting

PHASE3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Washington, Norfolk

Code:

NCT06607627

Conditions

Generalized Myasthenia Gravis

gMG

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Gefurulimab

National Collaborative to Improve Care of Children With Complex Congenital Heart Disease

Recruiting

Sponsor:

Children's Hospital Medical Center, Cincinnati

Location:

Washington, Falls Church, Baltimore, Harrisburgshow 53 more

Code:

NCT02852031

Conditions

Hypoplastic Left Heart Syndrome (HLHS)

Eligibility Criteria

Sex: All

Age: 0 - 15

Healthy Volunteers: Not accepted

Interventions

Collaborative Learning Network